---
layout: post
title: "行业政策利好频出 港A医药板块联动大涨 机构：板块估值处历史低位"
date: 2022-03-24 16:18:29 +0800
categories: emnews
tags: 东财滚动新闻
---
> 展望医药板块的未来，天风证券表示医药板块估值处于历史低位。创新药板块受多方面因素影响，目前整体估值已基本回落至疫情前水平，从中长期角度看，认为板块估值已经回归理性，当前时间节点具有较好的中长期布局价值。

<p>今日港A医药板块走强，<strong>CRO、新冠药、<span id="bk_90.BK1040"><a href="http://quote.eastmoney.com/unify/r/90.BK1040" class="keytip" data-code="90,BK1040">中药</a></span><span id="bkquote_90.BK1040"></span>等概念涨幅居前</strong>，A股<span id="stock_1.600511"><a href="http://quote.eastmoney.com/unify/r/1.600511" class="keytip" data-code="1,600511">国药股份</a></span><span id="quote_1.600511"></span>、<span id="Info.116.02607"><a href="http://quote.eastmoney.com/unify/r/116.02607" class="keytip" data-code="116,02607">上海医药</a></span>、<span id="stock_1.600056"><a href="http://quote.eastmoney.com/unify/r/1.600056" class="keytip" data-code="1,600056">中国医药</a></span><span id="quote_1.600056"></span>涨停，港股<span id="Info.116.01801"><a href="http://quote.eastmoney.com/unify/r/116.01801" class="keytip" data-code="116,01801">信达生物</a></span>涨8.19%，<span id="Info.116.03759"><a href="http://quote.eastmoney.com/unify/r/116.03759" class="keytip" data-code="116,03759">康龙化成</a></span>涨6.18%，<span id="Info.116.02196"><a href="http://quote.eastmoney.com/unify/r/116.02196" class="keytip" data-code="116,02196">复星医药</a></span>涨6.57%。</p><p>消息面上，国家卫健委发布《新型冠状病毒肺炎诊疗方案(试行第九版)》，在核酸检测基础上，增加抗原检测作为补充，将<span id="stock_106.PFE"><a href="http://quote.eastmoney.com/unify/r/106.PFE" class="keytip" data-code="106,PFE">辉瑞</a></span><span id="quote_106.PFE"></span>新冠口服药Paxlovid和腾盛博药中和抗体加入诊疗方案，对中医治疗内容进行了修订完善。</p><p>另外，多个医药股发布超预期<span id="Info.3321"><a href="http://data.eastmoney.com/bbsj/" class="infokey">业绩</a></span>预告，如CRO龙头<span id="Info.116.02359"><a href="http://quote.eastmoney.com/unify/r/116.02359" class="keytip" data-code="116,02359">药明康德</a></span>21年<span id="Info.3323"><a href="http://data.eastmoney.com/bbsj/" class="infokey">营业收入</a></span>约229.02亿元，同比增加38.5%，年报靓丽，带动其他股跟涨。</p><p>展望医药板块的未来，<span id="stock_1.601162"><a href="http://quote.eastmoney.com/unify/r/1.601162" class="keytip" data-code="1,601162">天风证券</a></span><span id="quote_1.601162"></span>表示<strong>医药板块估值处于历史低位</strong>。创新药板块受多方面因素影响，目前整体估值已基本回落至疫情前水平，从中长期角度看，认为板块估值已经回归理性，当前时间节点具有较好的中长期布局价值。</p><p><span id="Info.116.02611"><a href="http://quote.eastmoney.com/unify/r/116.02611" class="keytip" data-code="116,02611">国泰君安</a></span>表示，近期医药行业政策落地仍然处于密集窗口期，基数效应消散，分化开始加大。当前市场风险偏好低，对于成长型品种有抑制，建议关注业绩增速较高的品种。如业绩增速提升板块、高景气延续板块：<strong>CXO、医疗设备、部分创新药等</strong>。</p><p><span id="stock_1.600109"><a href="http://quote.eastmoney.com/unify/r/1.600109" class="keytip" data-code="1,600109">国金证券</a></span><span id="quote_1.600109"></span>看好新冠产业链上游原料药板块和医药上游供应链，建议关注业绩高成长兑现和疫情防控双主线，相关公司有：<strong><span web="1" href="http://quote.eastmoney.com/unify/r/116.02359" class="em_stock_key_common" data-code="116,02359">药明康德</span>、<span id="stock_1.603456"><a href="http://quote.eastmoney.com/unify/r/1.603456" class="keytip" data-code="1,603456">九洲药业</a></span><span id="quote_1.603456"></span>、<span id="Info.116.01093"><a href="http://quote.eastmoney.com/unify/r/116.01093" class="keytip" data-code="116,01093">石药集团</a></span>、<span id="stock_1.603520"><a href="http://quote.eastmoney.com/unify/r/1.603520" class="keytip" data-code="1,603520">司太立</a></span><span id="quote_1.603520"></span>、<span web="1" href="http://quote.eastmoney.com/unify/r/116.02607" class="em_stock_key_common" data-code="116,02607">上海医药</span></strong>等。</p><h3 class="emh3">附A股通、港股大市值医药股名单</h3><center><img src="https://dfscdn.dfcfw.com/download/D24617436529235851809_w798h1120.jpg" width="580" emheight="814" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><center><img src="https://dfscdn.dfcfw.com/download/D25652674254964481481_w798h1120.jpg" width="580" emheight="814" style="border:#d1d1d1 1px solid;padding:3px;margin:5px 0;" /></center><p class="em_media">（文章来源：哈富<span id="bk_90.BK0473"><a href="http://quote.eastmoney.com/unify/r/90.BK0473" class="keytip" data-code="90,BK0473">证券</a></span><span id="bkquote_90.BK0473"></span>）</p>

<http://hk.eastmoney.com/news/1797,202203242321852313.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)